+157.2%
MRNA vs VICI
-11.8%
+169.1%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 6mo.
| Period | Portfolio | VICI | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +0.4% | +5.0% | +4.9% |
| 7D | -1.1% | -2.3% | +1.2% | +1.7% |
| 30D | +126.1% | -4.8% | +130.9% | +138.0% |
| 3M | +190.0% | -10.1% | +200.1% | +197.0% |
| 6M | +157.2% | -9.7% | +166.9% | +164.3% |
| All | +157.2% | -11.8% | +169.1% | +164.3% |
Cumulative growth
Daily Returns
Daily percentage return beside VICI.
Daily Out/Under-Performance
Portfolio return minus VICI return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × VICI return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 6mo: compounded portfolio wealth divided by compounded VICI wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
6mo analysis · Full analysis span regression · 6 months rolling